UPDATE 2-Jazz Pharmaceuticals to settle U.S. probe for $57 million
May 08, 2018 at 20:53 PM EDT
BOSTON, May 8 (Reuters) - Jazz Pharmaceuticals Plc said on Tuesday it had agreed to pay $57 million to resolve a U.S. probe into its financial support of charities that offer assistance to Medicare patients seeking help to cover out-of-pocket drug costs.
